Vlasschaert, Caitlyn
Lanktree, Matthew B. http://orcid.org/0000-0002-5750-6286
Rauh, Michael J. http://orcid.org/0000-0002-8346-5537
Kelly, Tanika N.
Natarajan, Pradeep http://orcid.org/0000-0001-8402-7435
Article History
Accepted: 29 September 2023
First Online: 26 October 2023
Competing interests
: P.N. reports research grants from Allelica, Apple, Amgen, Boston Scientific, Genentech/Roche and Novartis, personal fees from Allelica, Apple, AstraZeneca, Blackstone Life Sciences, Foresite Labs, Genentech/Roche, GV, HeartFlow, Magnet Biomedicine and Novartis, scientific advisory board membership of Esperion Therapeutics, Preciseli and TenSixteen Bio, scientific co-founder of TenSixteen Bio, equity in Preciseli and TenSixteen Bio, and spousal employment at Vertex Pharmaceuticals, all unrelated to the present work. M.B.L. reports received speaking and advisory board fees from Bayer, Otsuka, Reata and Sanofi. The remaining authors declare no competing interests.